1. IO Biotech Files 8-K: Bankruptcy, Debt Acceleration, and Executive Departures Signal Crisis
IO Biotech, Inc. has triggered a critical SEC disclosure, filing an 8-K form that simultaneously flags bankruptcy proceedings, a major debt acceleration event, and the departure of key directors or officers. This multi-faceted filing is a rare and severe corporate signal, indicating a cascading financial and governance...